TCAs | | | | |
Imipramine | Human | Orthostatic hypotension | 1–5 g/kg/day | Giardina et al., 1985 |
Imipramine | Human | Orthostatic hypotension | 100 mg/day | Thayssen et al., 1981 |
Imipramine | Human | Orthostatic hypotension | ∼225 mg/day | Glassman et al., 1979 |
Imipramine | Rabbit | Decrease | 29 mg/kg | Hughes and Radwan, 1979 |
Imipramine | Dog | Decrease | 0.1–10 mg/kg | Kato et al., 1974 |
Imipramine | Dog | Decrease | 1–10 mg/kg | Yokota et al., 1987 |
Imipramine | Human | Orthostatic hypotension | 200 mg/day | Guelfi et al., 1983 |
Imipramine | Dog | Decrease | 0.5 mg · kg−1 · min−1 | Lindbom et al., 1982 |
Nortriptyline | Human | Orthostatic hypotension | 0.5–3.5 mg/kg/day | Giardina et al., 1985 |
Nortriptyline | Human | No change | 40 mg/day | Thayssen et al., 1981 |
Amitriptyline | Rabbit | Decrease | 15 mg/kg | Hughes and Radwan, 1979 |
Amitriptyline | Dog | Decrease | 0–20 mg/kg | Lindbom et al., 1982 |
Amitriptyline | Dog | Decrease | 1–10 mg/kg | Yokota et al., 1987 |
Amitriptyline | Dog | Decrease | 0.1–10 mg/kg | Kato et al., 1974 |
Amitriptyline | Human | Decrease | 25 mg/day | Ogura et al., 1983 |
Amitriptyline | Human | No change | 75 mg/day | Penttilä et al., 2001 |
Maprotiline | Rabbit | Decrease | 34 mg/kg | Hughes and Radwan, 1979 |
Clomipramine | Dog | Decrease | 1–10 mg/kg | Yokota et al., 1987 |
Clomipramine | Human | Orthosatic hypotension | 150 mg/day | Christensen et al., 1985 |
Clomipramine | Dog | Decrease | 0–20 mg/kg | Lindbom et al., 1982 |
Desmethylimipramine | Human | Increase | 100 mg | Ross et al,. 1983 |
Desipramine | Human | No change | 100 mg/day | Chalon et al., 2003 |
MAO Inhibitors | | | | |
Rasagiline | Rat | No change | 0.2–1 mg/kg | Finberg et al., 2006 |
Rasagiline | Rat | No change | 1 mg/kg | Abassi et al., 2004 |
Rasagiline | Rat | Decrease | 10 mg/kg | Abassi et al., 2004 |
Selegiline | Rat | No change | 1–5 mg/kg | Finberg et al., 2006 |
Selegiline | Human | Orthostatic hypotension | 10 mg/day | Turkka et al., 1997 |
Selegiline | Rat | No change | 1 mg/kg | Abassi et al., 2004 |
Selegiline | Rat | Decrease | 10 mg/kg | Abassi et al., 2004 |
L-Deprenyl | Rat | No change | 5 mg/kg | Stevens et al., 1998 |
L-Deprenyl | Rat | Increase | 25 μg/100 g | Kerecsen and Bunag, 1989 |
Clorgyline | Rat | No change | 2 mg/kg | Finberg et al., 2006 |
Clorgyline | Rat | No change/decrease | 25 μg/100g | Kerecsen and Bunag, 1989 |
Clorgyline | Human | Decrease | 28 mg/day | Murphy et al., 1979 |
Harmaline | Rat | Decrease | 20 mg/kg | Marwood et al., 1985 |
Pargyline | Rat | Decrease | 100 mg/kg | Marwood et al., 1985 |
Pargyline | Rat | Decrease | 10 mg/kg | Fuentes et al., 1979 |
Pargyline | Human | Decrease | 87 mg/day | Murphy et al., 1979 |
Tranylcypromine | Rat | Decrease | 10 mg/kg | Marwood et al., 1985 |
Tranylcypromine | Rat | Decrease | 5 mg/kg | Ashkenazi et al., 1983 |
Tranylcypromine | Human | Orthostatic hypotension | 20–100 mg/day | Nolen et al., 1993 |
Tranylcypromine | Rat | Increase | 25 mg/kg | Finberg et al., 2006 |
Isoniazid | Rat | Decrease | 30–300 mg/kg | Vidrio et al., 2000 |
Brofaromine | Human | Orthostatic hypotension | 50–250 mg/day | Nolen et al., 1993 |
SSRIs | | | | |
Citalopram | Human | No change | 40 mg/day | Christensen et al., 1985 |
Citalopram | Human | No change | 40–60 mg/day | Pedersen et al., 1982 |
Citalopram | Human | No change | 20 mg/day | Penttilä et al., 2001 |
Fluvoxamine | Human | No change | 300 mg/day | Guelfi et al., 1983 |
Fluoxetine | Rat | Increase | 10–50 μg i.c.v. | Lazartigues et al., 2000 |
Fluoxetine | Rat | Decrease | 10 mg/kg | Sved et al., 1982 |
Fluoxetine | Human | Increase | 20 mg/day | Amsterdam et al., 1999 |
Paroxetine | Dog | Increase/ Decrease | 0.1–10 mg/kg | Yokota et al., 1987 |
Sertraline | Human, adolescent | No change | Up to 200 mg/day | Wilens et al., 1999 |
Sertraline | Human | No change | Up to 400 mg/day | Saletu et al., 1986 |
Zimeldine | Dog | Decrease | 1–20 mg/kg | Lindbom et al., 1982 |
Zimeldine | Human | No change | 100 mg/day | Saletu et al., 1986 |
SNRIs | | | | |
Milnacipran | Human | Increase | 0.2–0.8 mg/kg | Caron et al., 1993 |
Venlafaxine | Human | Increase | 75–225 mg/day | Perahia et al., 2008 |
Venlafaxine | Human | Decrease | 75–225 mg/day | Alexandrino-Silva et al., 2008 |
Venlafaxine | Human | Increase | 225–525 mg/day | Mbaya et al., 2007 |
Duloxetine | Rat | Decrease | 30 mg/day | Chudasama and Bhatt, 2009 |
Duloxetine | Human | Increase | 120–400 mg/day | Derby et al., 2007 |
Duloxetine | Human | No change | 60–120 mg/day | Perahia et al., 2008 |
Duloxetine | Human | No change | 40–120 mg/day | Bailey et al., 2006 |
Duloxetine | Human | Increase | 80 mg/day | Chalon et al., 2003 |
Sibutramine | Human | Decrease | 10–15 mg/day | Sharma et al., 2009 |
Sibutramine | Human | Basal increase, decrease in sympathetic stimulation | 15 mg/day | Birkenfeld et al., 2005 |
Sibutramine | Rat | No change | 5 mg/day | Chudasama and Bhatt, 2009 |
Sibutramine | Human | Decrease | 10–15 mg/day | Gaciong and Placha, 2005 |
Sibutramine | Human | Increase | 5–20 mg/day | McMahon et al., 2000 |